Author: Joseph Gerard

When family involvement helps and when it complicates addiction care: A clinical approach to boundaries

Posted on by Joseph Gerard

Members Of Support Group Sitting In Chairs Having Meeting

Written by Emily Carter,

Addiction rarely affects one person alone. Families often feel the strain early. Money problems may appear. Responsibilities may be missed. Crises at home can become frequent. Yet family support can also shape recovery. Family-based care can improve treatment engagement and family functioning. That makes family involvement clinically important. Still, more is not always better. Concern can become pressure. Support can become control. So, where is the balance? Family involvement helps when it supports recovery and respects patient choice. Safety matters. Privacy matters too. The goal is simple. Family participation should strengthen treatment, not take it over.

How can families support addiction treatment?

Families can make treatment easier. A relative may provide a ride. Another may help with childcare. These simple steps can remove barriers. Emotional support matters too. Recovery can feel stressful. It can also feel uncertain. A trusted person can reduce isolation. Family involvement can also improve communication around treatment. Research supports carefully structured family approaches for substance use disorders. Benefits may include reduced substance use and improved family functioning (Esteban et al., 2023). However, clinicians should still assess each situation individually. A supportive relationship can strengthen care. A highly conflicted relationship may have the opposite effect.

Family relationships may also feel tense during addiction. Some people may blame relatives or close friends. This can happen during conflict, shame, or denial. Understanding why addicts blame loved ones can help families understand this pattern. The goal is not to excuse harmful behavior. Instead, families can avoid turning every disagreement into a larger confrontation. Clinicians can also help relatives separate emotional reactions from treatment decisions.

Family roles may change throughout care. Early treatment may involve sharing important history. Families may also raise safety concerns. Later, their role may become less direct. They can support routines or encourage follow-up care. Discharge can create another shift. Relatives may help with transportation or home stability. However, they should not control every treatment decision.

Age also matters. Parents often play a larger role with adolescents. Younger patients may depend on adults for treatment access. Family-based interventions also have evidence among adolescents and young adults (Esteban et al., 2023). Adults usually have greater control over participation. They often decide which relatives or support people join their care.

How can families support recovery without enabling substance use?

Helping and enabling can look similar at first. The difference often comes down to accountability. Driving someone to treatment can support recovery. Paying repeated substance-related debts may do the opposite. It can reduce the impact of harmful choices. A similar problem may occur at work. A relative may repeatedly make excuses for missed shifts. That response may protect the person from consequences.

Giving unrestricted cash can also create risk. This is especially relevant when active substance use continues. However, withholding all support is not the answer either. Families can still provide help that supports treatment. They might assist with transportation or healthcare access. They can also offer emotional support. The important distinction involves what the help is reinforcing.

Support does not mean solving every problem. Families can encourage treatment without hiding serious consequences. They can show concern without accepting threatening behavior. They can also offer practical support without assuming full responsibility for recovery. Clear limits make that support healthier.

One useful approach is CRAFT. Community Reinforcement and Family Training works with concerned family members. It teaches communication and reinforcement strategies. It also focuses on encouraging treatment entry. A systematic review included 691 concerned significant others across 14 studies. CRAFT was twice as effective as comparison approaches for treatment entry (Archer et al., 2020). More intensive formats achieved particularly strong treatment-entry rates.

Should families stop helping completely? No. Useful support leaves room for responsibility. Enabling often develops from fear or repeated crises. Clinicians can address these patterns without blaming relatives. Specific examples are usually more useful than labels.

What do healthy boundaries look like during addiction recovery?

A boundary explains what someone will accept or refuse. It does not force another person to change. This distinction matters during addiction treatment. Family members may feel responsible for preventing substance use. In reality, they cannot control every decision.

A family may decide not to provide money for substances. They may also restrict access to household vehicles during intoxication. Threatening behavior can require another clear limit. These boundaries focus on safety rather than punishment. Other limits may focus on responsibility. A relative may stop making excuses to an employer. They may also refuse to hide repeated financial problems.

Good boundaries should be specific. They also need to be realistic. A rule has little value when nobody can maintain it. Consistency usually matters more than severity.

Clinicians need similar clarity. Families should know who may attend sessions. They should understand the purpose of their involvement. Respect for patient autonomy remains important throughout this process. Relatives can support treatment. However, they should not become informal therapists or investigators. Medication decisions should also remain within appropriate clinical care.

Clear boundaries protect several relationships at once. They support the patient-clinician relationship. They can also reduce confusion within the family. SAMHSA recommends defining family roles carefully during substance use disorder treatment (SAMHSA, 2020).

When can family involvement make treatment harder?

Family participation becomes difficult when the patient loses space to speak. One relative may answer every clinical question. Another may insist on joining every appointment. Constant monitoring can create similar problems. A patient who feels watched may become less open during care.

Treatment can also become harder when relatives challenge evidence-based recommendations. Someone may oppose medication for opioid use disorder. Another family member may define recovery only through complete abstinence. Such beliefs can conflict with individualized treatment planning. They may also create shame after recurrence.

Clinicians should pay attention to coercion. Family involvement should not become another form of control. The patient’s preferences remain important when consent rules allow choice. Some adults may want only limited family participation. Others may prefer a trusted friend or partner instead.

Safety deserves particular attention. Joint counseling may not be appropriate when violence is present. Coercive relationships can also make shared sessions unsafe. The same concern applies when retaliation is possible. SAMHSA advises careful assessment before using family-based treatment in situations involving violence (SAMHSA, 2020).

Past trauma can also shape participation. So can estrangement or longstanding conflict. Clinicians should explore these factors before assuming family involvement will improve care. Sometimes limited involvement is the safer clinical choice.

What can clinicians tell family members about addiction treatment?

Confidentiality often causes confusion. Relatives may want detailed updates because they are worried. Clinicians cannot always provide them. A useful distinction involves receiving information and disclosing information.

A family member may contact a clinician with an important concern. For example, they might report a suspected overdose. They might also describe a major behavioral change. Receiving that information does not automatically permit disclosure in return.

HIPAA may allow communication with people involved in care. However, disclosure generally depends on the circumstances. Patient agreement can also matter. Information shared should relate to the person’s involvement in care. Clinicians should not treat family participation as unlimited access to records.

Substance use disorder records can receive additional federal protection. These protections appear under 42 CFR Part 2. The 2024 final rule aligned some Part 2 requirements more closely with HIPAA. However, important protections remain. Compliance with the updated requirements was required by February 16, 2026 (HHS, 2026).

Clinicians should explain confidentiality early. Families should understand what can be discussed. They should also know what remains private. Clear expectations can prevent conflict later. They also support informed participation in treatment.

Does family therapy improve addiction treatment outcomes?

Family therapy can be useful, but it is not one treatment model. Different approaches serve different clinical situations. Some focus on communication and behavior within the household. Others focus on couples or adolescents. Broader addiction treatments may combine behavioral care with medication.

Research supports family-based approaches for substance use disorders. A systematic review examined recent family therapy research. It found benefits for substance use and family functioning (Esteban et al., 2023). A newer systematic review also examined randomized controlled trials. It included 15 trials. Eleven reported significant positive effects from family-based interventions. Those outcomes included reduced substance use or better family functioning.

Still, results vary. No single family model fits every patient. A couples-based approach may fit one adult. A youth-focused program may suit an adolescent better. CRAFT may be useful when a person resists treatment. Other families may need psychoeducation rather than formal family therapy.

Clinical selection matters. The approach should fit the patient’s needs. Relationship quality also matters. So does safety. Family therapy should support the treatment plan rather than compete with it.

How should families respond when relapse occurs?

Relapse can trigger strong reactions. Fear may become anger. Concern can turn into surveillance. Some relatives may threaten to withdraw all support. These responses are understandable. However, they may not improve treatment engagement.

A more useful response begins with reassessment. Continued substance use does not automatically mean treatment has failed. In many cases, relapse and recovery should be considered within the wider treatment process. A recurrence may show that part of the current plan needs adjustment.

Clinicians may reassess overdose risk. Medication may also require review. Treatment intensity can change when needed. Triggers and new stressors may deserve attention. The goal is to understand what changed before making the next clinical decision.

Families can support this process without taking control. They may encourage a return to treatment. They can help someone keep important appointments. They may also support prescribed medication. However, relatives cannot guarantee abstinence.

Family wellbeing deserves attention too. Addiction can place considerable psychological pressure on relatives. Research shows that interventions for affected family members can improve important wellbeing outcomes (McGovern et al., 2021). Families may need their own boundaries around finances and time. They should also protect their work and personal relationships.

Supporting recovery should not require constant monitoring. It should not make one relative responsible for every setback. Shared responsibility supports a healthier treatment environment.

How can clinicians decide the right level of family involvement?

There is no single correct level. Each case is different. The patient should have a meaningful voice. Clinicians can start by asking who the patient wants involved. They should also consider safety. A supportive relationship should not create fear or coercion.

Treatment goals offer another guide. Does the family member improve treatment participation? Do they provide useful collateral information? Does their presence support communication? These questions can help define an appropriate role.

The answer may change over time. A relative may help greatly during discharge. That does not mean they need every therapy session. Someone excluded during family conflict may become helpful later.

Family also does not always mean a blood relative. Some patients rely more on partners or close friends. Others may identify a caregiver as their main support person. Clinicians should focus on the relationship’s actual function.

Culture can also shape family roles. Some families expect shared healthcare decisions. Others place greater emphasis on individual privacy. Clinicians should explore these expectations rather than assume them.

Ultimately, family involvement helps when it strengthens care without taking over care. Good boundaries protect patient autonomy. They also support family well-being. Most importantly, they keep treatment focused on the patient’s clinical needs.

About the author

Emily Carter is a content writer with a focus on behavioral health, addiction treatment, recovery, and wellness. She creates clear, compassionate, and research-informed content designed to help readers better understand treatment options, mental health topics, and the recovery process. Her writing aims to make complex healthcare information more accessible while maintaining a respectful and supportive tone.

References

American Society of Addiction Medicine. (2024). Engagement and retention of nonabstinent patients in substance use treatment: Clinical considerations for addiction treatment providers. American Society of Addiction Medicine. https://www.asam.org/quality-care/clinical-recommendations/asam-clinical-considerations-for-engagement-and-retention-of-non-abstinent-patients-in-treatment

Archer, M., Harwood, H., Stevelink, S., Rafferty, L., & Greenberg, N. (2020). Community reinforcement and family training and rates of treatment entry: A systematic review. Addiction, 115(6), 1024–1037. https://doi.org/10.1111/add.14901

Esteban, J., Suárez-Relinque, C., & Jiménez, T. I. (2023). Effects of family therapy for substance abuse: A systematic review of recent research. Family Process, 62(1), 49–73. https://doi.org/10.1111/famp.12841

McGovern, R., Smart, D., Alderson, H., Araújo-Soares, V., Brown, J., Buykx, P., Evans, V., Fleming, K., Hickman, M., Macleod, J., Meier, P., & Kaner, E. (2021). Psychosocial interventions for family members affected by an adult relative’s substance use. International Journal of Environmental Research and Public Health, 18(4). https://pubmed.ncbi.nlm.nih.gov/

Substance Abuse and Mental Health Services Administration. (2020). Substance use disorder treatment and family therapy (Treatment Improvement Protocol 39). U.S. Department of Health and Human Services. https://store.samhsa.gov/product/tip-39-substance-use-disorder-treatment-and-family-therapy/pep20-02-02-012

U.S. Department of Health and Human Services, Office for Civil Rights. (2026). Fact sheet: 42 CFR Part 2 final rule. https://www.hhs.gov/hipaa/for-professionals/regulatory-initiatives/fact-sheet-42-cfr-part-2-final-rule/index.html

 

 

 

Please also review AIHCP’s Substance Abuse Practitioner Program and  CE courses to see if it meets your academic and professional goals.

What to Delegate First When Your Practice Is Growing

Posted on by Joseph Gerard

A young doctor is sitting in the clinic and talking on telephone and doing paperwork that should be done by an an admin assistantWritten by Ashleigh Atuahene,

Before I, Ashleigh, co-founded Ataraxis, I spent years working inside the kind of practices I now help other people staff. I started on the administrative side, spending a few years in a physician’s office doing patient intake, scheduling, insurance verification, and prior authorization. Later I took a role providing one-on-one ABA therapy under a licensed therapist, and once that clinic realized I already had an admin and insurance background, the same kind of work found its way on my desk there too. Over time I handled intake, scheduling, chart QA, prior auths, and insurance verification across pediatric, internal medicine, and behavioral health. So when I talk about what to delegate first, I am not repeating something I read in an operations handbook. I watched practices get this right, and I watched practices get it wrong, sometimes from inside the same building.

Here is the question I hear most often from growing practices: what should I hand off first? Most owners assume the answer is “someone to answer the phones.” Sometimes it is. But the real answer depends on one thing, and that is how your practice gets paid.

Start With How You Get Paid

If you accept insurance, delegate billing and coding first. Not the phones, not the calendar. Billing. This is the part owners resist, because the phone is loud and the billing is quiet. The phone interrupts you all day, so it feels like an emergency. Billing sits in a queue and does not shout, so it feels like it can wait. It cannot. Every claim that goes out late, coded wrong, or missing a prior authorization is money you earned and may never collect. In behavioral health especially, where claims are denied more often than in general medicine, the person who owns your billing is the person who owns your cash flow. Hand that off to someone who does it well, and do it early.

If your practice is out-of-pocket or cash-pay, the situation flips. When there are no claims to chase, your bottleneck is not billing, it is access. In that case, delegate everything that touches the patient but does not generate a billable hour: new patient intake, new patient questions, taking messages, routing questions meant for the provider, screening the sales reps who want “just five minutes” with the office, and, yes, the scheduling everyone expects. The clinical hour is the product. Anything that pulls the provider out of that hour without adding revenue should be delegated, and a good virtual medical receptionist can absorb most of it.

Reducing Friction

When a practice grows, the growth is not invisible to your patients. They feel it. Scheduling gets harder to manage. Reaching the provider takes longer. Those small frictions are the first thing a patient notices, and they are the first thing that makes a patient wonder whether they should look elsewhere.

The goal of your first hire is to keep the patient from feeling the growth at all. Ideally, a practice at forty patients should feel as easy to work with as it did at ten. That does not happen by accident. It happens because someone whose whole job is responsiveness is standing between your expanding schedule and the person trying to book into it. 

The Cost of a Missed Moment

The larger a practice gets, the more opportunities start to fall through the cracks. Imagine a solo provider with a handful of patients. It is simple to manage the schedule, move an appointment, stay on top of notes, and answer a quick question between sessions. Now picture that same provider booked back to back all day. The moment their calendar fills up, they lose the ability to manage those small functions effectively.

Here is a real-life example I saw over and over. Your one o’clock is running late and calls to reschedule. If you have a light day, you see the message and move them in two minutes. If you are in back-to-back sessions with no admin, you will not even see that message until it is already one o’clock. That patient could have been rescheduled and the slot backfilled. Instead you have an empty hour, a frustrated patient, and a note you still have to write. Multiply that by a full calendar and you can see how a growing practice starts leaving money and goodwill on the table, not because demand dropped, but because no one was available to catch the moment.

Money Is to the Business What Gas Is to the Car

No one understands the value of the clinical hour better than the provider delivering it. You are paid on billable hours. Accumulate them and the practice runs. Let them drop and you cannot cover overhead, and you certainly cannot pay yourself without dipping into reserves. Money is to the business what gas is to the car. The good news about growth is that it brings more billable hours. The hard news is that it also brings a flood of administrative work, and that work does not bill.

In a landmark time-and-motion study, physicians spent close to two hours on documentation and desk work for every single hour of direct patient care (Sinsky et al., 2016). Behavioral health is often heavier still: a fifty-minute session usually generates another twenty-plus minutes of notes, before you consider billing, intake, or authorizations. And prior authorization deserves its own line. The American Medical Association found that physicians and their staff spend an average of thirteen hours per week, per physician, completing prior authorizations, working through roughly thirty-nine requests each week (American Medical Association, 2025). That is more than a full workday, every week, spent on paperwork where the rules keep changing.

So the math is simple, even if the decision feels hard. Your time is finite, and growth makes that scarcity impossible to ignore. Every hour you spend on a task someone else could do is an hour you are not billing. Why waste billable hours when you can pay someone twelve dollars an hour overseas, or thirty dollars an hour locally before benefits, to do well, when that same hour of your time is worth hundreds? Hiring is not the cost. Doing your own admin is the cost. It just does not show up on an invoice.

When You Get the Order Wrong

Delegating well is not only about what you hand off. It is about the order you do it in, and about being honest with yourself when something is not working. The practices I have been part of taught me this in different ways.

Hiring Too Late

At a small ABA practice, there was one admin who handled the phones, the schedule, and parent questions. She was capable, but she had little experience with insurance verification or prior auths and no time to learn them. I came in as an ABA therapist, and once they learned about my earlier admin experience, insurance work for three providers got delegated to me, the family therapist, the speech-language pathologist, and the ABA side. By the time I took it over, the practice was already swimming in denials and patching broken workflows. We got it back on track, but you cannot fully recover the time and income lost to mistakes made months earlier. Billing delegated late is more expensive than billing delegated early, because the denials compound while you wait.

Too Slow to Change

I also worked with a solo speech-language pathologist who did one thing right and one thing wrong. She hired an admin first, then brought on a billing specialist through an agency later, which is a reasonable order. Her mistake was not listening. When the billing specialist told her the claims were not collectible as submitted and the system was fighting them, she kept pushing to make it work instead of finding someone more adept. Even if a stronger specialist had cost more, she would have come out ahead. Delegation only works if you trust the person you delegated to, or replace them, rather than overriding the expertise you hired.

Getting the First Hire Right

More recently, I watched these same principles play out from the other side of the table as my team worked closely to help staff a small group therapy practice in San Jose with three clinicians. They were making their very first hire. The founder was not in crisis mode, which is exactly the point. She was still seeing her own clients while personally carrying the billing, the session submissions, and the scheduling, and what wore her down was the constant switching between being a clinician and being an administrator. In her words, she needed another brain.

What made this one go right came down to two decisions. First, she hired before the wheels came off, while she still had the bandwidth to onboard someone properly instead of handing over a mess. Second, she was honest about what mattered most. Her practice is bilingual, and an assistant who also spoke Mandarin would have been a nice bonus, but when it came down to it she chose deep behavioral health experience and a strong command of HIPAA and her EHR over the language skill. 

The person she brought on had a psychology background and already knew the systems her practice ran on, and she took over the session submissions, the billing, the out-of-network claims, and the scheduling at about twenty hours a week. That was enough to hand the founder her clinical focus back. The last thing she did right is the piece most first-time hirers skip: she wrote down her processes before the start date, so her new assistant was working from clear documentation instead of guessing. Get the right person and the right instructions in place, and the handoff is usually simple.

Where to Start This Week

If you take one thing from my experience, let it be this. Decide how you get paid, and delegate that pressure point first: billing if you bill insurance, patient-facing overhead if you are cash-pay. Delegate early rather than at the point of pain, because the mistakes made while you wait are the expensive ones. Trust the specialists you bring in, or move on quickly if they do not perform, but do not spend your own high-value hours overriding them. Growth is a good problem. It only becomes a bad one when the administrative load grows faster than your willingness to hand it off.

 

Ashleigh headshotAuthor’s Bio:

Ashleigh Atuahene is co-founder of Ataraxis. Before building the company, she provided one-on-one ABA therapy under a licensed therapist and spent years in healthcare administration, handling patient intake, scheduling, prior authorization, insurance, and documentation across pediatric, internal medicine, and behavioral health practices.

 

References

American Medical Association. (2025). 2024 AMA prior authorization physician survey. American Medical Association.

Sinsky, C., Colligan, L., Li, L., Prgomet, M., Reynolds, S., Goeders, L., Westbrook, J., Tutty, M., & Blike, G. (2016). Allocation of physician time in ambulatory practice: A time and motion study in 4 specialties. Annals of Internal Medicine, 165(11), 753–760.

 

 

 

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

The Growing Role of Peptide Research in Regenerative Medicine

Posted on by Joseph Gerard

Nurse Holding a TabletWritten by Harry Wolf,

Regenerative medicine – as you are sure to know – focuses on repairing damaged tissues, restoring function, and combating cellular degeneration. Now, how can targeted cellular signaling change the future of tissue recovery and disease management? 

At the center of this paradigm shift is peptide research – which analyzes short chains of amino acids that serve as specific biological messengers within physiological pathways.

These bio-active sequences direct complex physiological responses – including tissue repair, anti-inflammatory cascades, and cellular repair mechanism triggers. 

For researchers, clinicians, and health care educators, studying precise molecular signals provides critical insights into cellular recovery. High-purity compounds remain essential for gathering valid experimental data during preclinical research.

Accelerating MSK Tissue Repair and ECM Reconstruction

Cellular regeneration within musculoskeletal (MSK) structures requires complex signaling pathways – to orchestrate connective tissue healing, that is. Tendons, ligaments, and cartilage possess limited intrinsic vascularization – which often slows natural recovery processes. 

Specific synthetic and naturally occurring peptides accelerate extracellular matrix (ECM) reconstruction. How? By directly upregulating collagen synthesis and promoting localized fibroblast activity.

Targeted amino acid sequences stimulate focal adhesion kinase pathways – enhancing structural protein deposition at injured sites. 

The molecular pathways involved in connective tissue regeneration rely on several documented signaling mechanisms:

  • Upregulation of collagen type I and type III expression in damaged connective tissues
  • Enhancement of tenocyte proliferation during early-phase structural healing
  • Modulation of focal adhesion kinase activity within localized extracellular matrices

Continuous investigation into structural signaling peptides provides critical models for understanding tissue biomechanics. Scientists leverage these specific models to observe structural recovery speeds and matrix organization under controlled in vitro conditions.

The initial mechanical cascades following connective tissue trauma determine long-term architectural integrity within the affected site. 

Natural healing mechanisms often falter in dense connective tissue – due to limited blood supply, which severely restricts the rapid delivery of vital cellular nutrients and growth factors. 

When localized vascularization is inadequate, micro-tears in collagen networks cannot efficiently assemble necessary repair proteins – leaving structural matrixes vulnerable to chronic degradation.

Targeted molecular therapies seek to bypass these physiological bottlenecks. How? By delivering concentrated signalers straight to impaired cellular zones. 

Modulating Inflammatory Cascades 

Persistent, low-grade inflammation… It often leads to progressive tissue destruction and chronic degenerative pathology. Bio-active peptide sequences function as precise immunomodulators – shifting microenvironments from pro-inflammatory states toward active repair phases. 

By regulating specific cytokine release pathways, these signaling molecules help mitigate systemic and tissue-level stress.

Targeted peptide administration can suppress excessive nuclear factor kappa B (NF-κB) activation – effectively dampening downstream inflammatory signaling. Reducing excessive oxidative stress protects vulnerable cell populations from premature apoptosis.

Immunomodulatory peptides control systemic stress – through multiple targeted cellular actions, such as:

  • Suppression of pro-inflammatory cytokines including TNF-alpha and IL-6
  • Regulation of the NF-κB signaling pathway to control inflammatory cascades
  • Downregulation of reactive oxygen species generation within microvascular cells
  • Promotion of macrophage polarization 

Controlling localized inflammatory microenvironments allows underlying biological tissues to heal without secondary structural damage. Understanding these immunomodulatory cascades remains a high priority for scientists designing therapies for systemic degenerative conditions.

Suppression of inflammatory cascades protects damaged tissues from secondary cellular degradation. Excessive inflammatory activity elevates local oxidative stress – triggering widespread cellular apoptosis and breakdown of delicate matrix structures. 

Regulating nuclear factor kappa B activation stabilizes impaired cellular microenvironments, thus effectively preventing downstream pathological damage.

Stimulating Angiogenesis and Vascularization 

Effective tissue recovery… It requires adequate vascular supply to deliver oxygen, nutrients, and cellular precursors to damaged sites. Angiogenic peptide sequences act directly on endothelial cells.

They encourage microvascular sprouting and vessel formation – within ischemic biological environments, that is.

Specific peptide fragments mimic natural growth factors, such as vascular endothelial growth factor (VEGF), to stimulate functional vessel development. 

Furthermore… Endothelial cell migration increases significantly when targeted signaling molecules engage localized cell surface receptors.

Primary angiogenic pathways observed during microvascular regeneration? They include:

  • Activation of vascular endothelial growth factor receptor pathways in microvascular cells
  • Acceleration of capillary sprout formation within hypoxic tissue models
  • Enhancing microvascular endothelial cell migration 

Re-establishing microvascular networks transforms dense and damaged cellular structures into dynamic, recovering tissues. Research into angiogenic signaling molecules continues to expand practical knowledge regarding ischemic tissue recovery and wound healing dynamics.

Ischemic tissue conditions present a severe challenge for cellular repair. Why? Because blood flow restriction deprives affected areas of oxygen and vital nutrients. 

Without adequate vascularization, natural healing halts, often leaving structural networks compromised. Targeted signaling peptides offer a promising approach to re-establishing microvascular networks – and supporting biological recovery.

Clinical insights underscore how critical rapid vascular restoration is for long-term tissue viability. Targeted angiogenic peptides mimic essential growth factors (like vascular endothelial growth factor) to actively stimulate functional vessel formation. 

By engaging localized cell surface receptors, these specialized molecular sequences encourage microvascular sprouting and endothelial cell migration – across extracellular matrix boundaries.

For researchers conducting laboratory trials on ischemic tissue repair models, maintaining exact experimental parameters requires high-purity, standardized compounds. 

Thankfully, researchers can purchase third-party tested, high-purity research peptides with public batch-specific certificates online that deliver consistent biological signaling. 

Utilizing standardized compounds helps eliminate variable baseline metrics – during delicate cellular migration studies, that is.

Enhancing Neurological Regeneration

Neurologicalregeneration… It presents a significant challenge. The challenge is due to the complex architectural framework and limited intrinsic regenerative capacity of the central nervous system. 

Neurotrophic peptide sequences demonstrate remarkable potential in shielding neurons from metabolic stress – while stimulating axonal outgrowth and synaptic plasticity.

Neuroprotective peptides promote neurite outgrowth – and support glial cell health under ischemic and neurotoxic conditions. These signals activate brain-derived neurotrophic factor (BDNF) signaling cascades, thus preserving functional neural circuits.

Targeted neuroprotective sequences protect central nervous system architecture through key biological mechanisms:

  • Activation of BDNF-mediated cellular survival pathways in compromised neurons
  • Promotion of neurite elongation and synaptic connection formation
  • Protection of neuronal cell bodies against glutamate-induced excitotoxicity

Investigating these neuroprotective mechanisms opens critical pathways for understanding neural recovery after physical injury or neurodegenerative stress. Targeted signaling peptides provide valuable tools for mapping complex biological interactions within the brain.

Central nervous system damage… It creates severe biological obstacles because delicate neural networks lack rapid self-repair mechanisms. When ischemia or metabolic toxicity impacts cellular integrity, localized neural pathways quickly break down. 

Advanced peptide therapies… They provide critical biochemical signaling – to shield vulnerable neurons and encourage functional recovery.

Promoting Cellular Lifespan and Metabolic Function 

Now, let’s look at biological aging and cellular fatigue. They stem from progressive mitochondrial dysfunction and impaired metabolic signaling. 

Mitochondria act as the primary energy hubs of cellular networks – converting nutrients into functional adenosine triphosphate (ATP) in order to drive physiological processes. 

When mitochondrial pathways experience metabolic stress or structural deterioration, tissues suffer a decline in energy production – leading to premature biological aging and impaired functional recovery.

Targeted peptide sequences play a pivotal role in maintaining mitochondrial homeostasis and boosting cellular longevity. Specific metabolic peptides optimize mitochondrial biogenesis by activating peroxisome proliferator-activated receptor gamma coactivator 1-alpha pathways. 

By upregulating PGC-1α expression, these signaling molecules stimulate the formation of healthy new mitochondria while protecting existing structures from metabolic breakdown.

Scientists conducting targeted cellular metabolic research frequently acquire high-purity peptides to conduct precise, controlled assays. 

Obtaining reliable compounds allows researchers to accurately measure changes in cellular oxygen consumption, ATP production rates, and mitochondrial membrane potential – under stressful microenvironmental conditions, that is.

Key biological processes involved in peptide-mediated mitochondrial support include:

  • Upregulation of PGC-1α signaling pathways to promote mitochondrial biogenesis
  • Protection of mitochondrial membrane potential against metabolic stress
  • Enhancement of cellular ATP synthesis across metabolic tissue structures
  • Suppression of premature senescence in high-energy cellular environments

Mitigating mitochondrial decay allows biological structures to sustain higher metabolic outputs while resisting environmental stress factors. 

Investigating these targeted mitochondrial signaling pathways offers important research avenues for advancing cellular longevity and metabolic recovery protocols.

Counteracting Cellular Senescence and Matrix Degradation

Age-related tissue deterioration and chronic micro-trauma often induce cellular senescence. If you don’t know, that is a state where damaged cells permanently arrest their cell cycle while actively secreting pro-inflammatory signals. 

The phenomenon, known as the senescence-associated secretory phenotype (SASP), accelerates the degradation of surrounding extracellular matrix (ECM) components like elastin and structural fibronectin. 

When senescent cells accumulate, local repair signaling stalls – leaving surrounding healthy tissue vulnerable to progressive structural weakening.

Targeted peptide therapeutics serve as selective modulators to interrupt these degenerative loops. 

Specific peptide fragments encourage senolytic activity by selectively targeting anti-apoptotic pathways in senescent populations, clearing dysfunctional cells from the tissue microenvironment. 

By removing these sources of chronic signaling interference, adjacent progenitor cells can effectively respond to localized growth cues and initiate natural matrix restoration.

Key cellular outcomes associated with peptide-driven senescence modulation include:

  • Downregulation of SASP-related MMPs in aging connective tissue
  • Stabilization of pericellular matrix structures against enzymatic degradation
  • Restoration of localized cell-to-cell communication networks within dense tissue beds
  • Re-activation of quiescent stem cell niches to support long-term physiological renewal

Regulating cellular senescence and preventing matrix breakdown provides a critical foundation for sustained regenerative outcomes. By stabilizing the surrounding microenvironment, targeted signaling sequences ensure that newly restored tissue maintains its functional durability.

Future Directions

Peptide research continues to redefine the boundaries of regenerative medicine. How? By offering targeted molecular tools that regulate essential cellular processes. 

From extracellular matrix reconstruction to targeted neuroprotection, these biological messengers provide high-resolution insights into tissue recovery.

As scholars and health care professionals continue exploring molecular therapies, access to precise experimental data remains vital for advancing clinical knowledge. 

Hopefully this article has been of interest. If that is the case, check out some of our other related content. 

Author bio: Harry Wolf is a freelance writer. For almost a decade, he has written on topics ranging from healthcare to business leadership for multiple high-profile websites and online magazines.

References

  • Alzaydi, A., Barbhuiya, R. I., Routray, W., Elsayed, A., Singh, A., 2023, Bioactive peptides: Synthesis, applications, and associated challenges, Wiley Online Library.

https://onlinelibrary.wiley.com/doi/full/10.1002/fbe2.12057

  • Unauthored, 2023, Understanding the mechanisms of cell regeneration, MitoQ blog.

https://uk.mitoq.com/blogs/journal/understanding-the-mechanisms-of-cell-regeneration

  • Bioeng, N. R., 2023, Synthetic extracellular matrices with function-encoding peptides, National Library of Medicine.

https://pmc.ncbi.nlm.nih.gov/articles/PMC10127181/

  • Hall, J. E., Fu, W., Schaller, M. D., 2011, Focal Adhesion Kinase: Exploring FAK Structure to Gain Insight into Function, Science Direct.

https://www.sciencedirect.com/science/chapter/bookseries/abs/pii/B9780123860415000054

  • Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J., 2024, NF-κB in biology and targeted therapy: new insights and translational implications, Nature.

https://www.nature.com/articles/s41392-024-01757-9

  • Wang, Y. F., Xu, X., Fan, X., Zhang, C., Wei, Q., Wang, X., Guo, W., Xing, W., Yu, J., Yan, J. L., & Liang, H. P., 2011, A Cell-penetrating Peptide Suppresses Inflammation by Inhibiting NF-κB Signaling, National Library of Medicine.

https://pmc.ncbi.nlm.nih.gov/articles/PMC3188757/

  • Unauthored, 2024, Vascular Endothelial Growth Factor (VEGF) assay, Newcastle upon Tyne Hospitals, NHS Foundation Trust.

https://laboratories.newcastle-hospitals.nhs.uk/test-directory/vascular_endothelial_growth_factor/

  • Adak, A., Das, G., Barman, S., Mohapatra, S., Bhunia, D., Jana, B., & Ghosh, S., 2017, Biodegradable Neuro-Compatible Peptide Hydrogel Promotes Neurite Outgrowth, Shows Significant Neuroprotection, and Delivers Anti-Alzheimer Drug, ACS Publications.

https://pubs.acs.org/aamick/article-abstract/9/6/5067/702002/Biodegradable-Neuro-Compatible-Peptide-Hydrogel?redirectedFrom=fulltext

  • Bathina, S., Das, U. N., 2015, Brain-derived neurotrophic factor and its clinical implications, National Library of Medicine.

https://pmc.ncbi.nlm.nih.gov/articles/PMC4697050/

  • Dunn, J., Grider, M. H., 2023, Physiology, Adenosine Triphosphate,  National Library of Medicine.

https://www.ncbi.nlm.nih.gov/books/NBK553175/

 

 

Please also review AIHCP’s Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Managing Autonomic Instability During Acute Substance Withdrawal

Posted on by Joseph Gerard

Woman Having Counselling Session Substance Abuse Practitioners can help individuals understand their unique situation with addiction and the best ways to fight it. Please also review AIHCP's Substance Abuse Practitioner Training Program

Written by Charles Schubert

Abruptly stopping nervous system depressants can lead to a sudden and dangerous surge in sympathetic activity. This causes the heart rate to spike, blood pressure to rise sharply, and body temperature to climb to life-threatening levels. 

These changes happen fast. Can quickly become dangerous. That’s why managing acute withdrawal must be done under the care of trained professionals right away.

This guide breaks down the neurobiological mechanisms driving autonomic instability and outlines the clinical interventions essential to stabilize patients and prevent systemic collapse.

Neurobiological Mechanisms of Autonomic Hyperactivity

The central nervous system balances itself through inhibitory and excitatory neural stimuli. Inhibitory substances stimulate the inhibitory mechanism of the body but inhibit excitation in the brain. Natural inhibition neurotransmitters develop tolerance in the body as a result of prolonged use.

On the other hand, the brain secretes an increased amount of excitatory neurotransmitters in order to remain active. In the case of sudden cessation of drug use, this mechanism does not work because there are no inhibition neurotransmitters for the overactive neurons in the brain.

Neurotransmitter Imbalance and Receptors

This mechanism of physiological reaction is based on an imbalance between GABA and glutamate. The regular use of the drug causes desensitization of GABA receptors.

As a way of balancing out the constant inhibition, glutamate function is increased at NMDA receptor sites. Upon withdrawal of the depressant drug from the bloodstream, the glutamate receptors fire uncontrolled, causing excessive excitement in neurons.

Central Noradrenergic Outflow

The locus coeruleus serves as the primary noradrenergic nucleus in the brainstem, controlling systemic sympathetic tone. Under normal conditions, inhibitory receptors regulate local norepinephrine production.

During acute withdrawal, the abrupt loss of inhibition triggers uncontrolled neural firing. Several primary neurochemical shifts occur simultaneously during this rapid sympathetic surge:

  • Elevated catecholamine release throughout central pathways
  • Uninhibited signaling from the locus coeruleus
  • Heightened stimulation of arterial smooth muscle

This central surge spills over into the peripheral autonomic nervous system, causing severe stress that directly impacts cardiac tissue and metabolic function.

Regional Data on Sudden Cessation

According to research published by the National Center for Biotechnology Information, approximately 50% of individuals with alcohol dependence experience noticeable physical withdrawal symptoms when stopping consumption. Across major metro hubs in North Georgia and the greater Southeastern United States, clinical admissions for acute detoxification have increased significantly as regional healthcare systems expand community-based emergency intervention networks to handle rising demand in urban treatment centers.

Physiological Manifestations and Clinical Assessment

Autonomic hyperactivity affects multiple body systems at once as central inhibition breaks down. In high-acuity scenarios, clinicians closely monitor core physiological parameters to catch early markers of systemic overload.

The body shows clear physical signs when the autonomic nervous system becomes hyperactive:

  • Fast heart rate and high blood pressure
  • Heavy sweating and high body temperature
  • Muscle tremors and constant restlessness physical warning signs physical warning signs

Image Source: Gemini

Spotting these physical warning signs early helps medical teams change their care plans before patients feel very bad. Because managing these compounding shifts needs strict clinical oversight, putting patients in a structured detox placement in Atlanta gives them constant all‑day monitoring.

To deal with these instabilities safely, special clinical places, like Inner Voyage Recovery Center, watch vital signs all the time and use quick stabilization steps that help stop the body from being overloaded during early withdrawal.

Cardiovascular System Responses

The continuous exposure to catecholamines imposes immense stress on the cardiovascular system during withdrawal from stimulant abuse. Tachycardia causes decreased perfusion of the myocardium. In this case, the need for oxygen rises, while flow falls.

Vasoconstriction of systemic circulation vessels can lead to increased peripheral vascular resistance and ultimately raise systolic and diastolic blood pressure levels. The patient receiving treatment at the emergency departments in cities such as Atlanta may suffer from ACS, hypertensive crisis, and ventricular arrhythmias due to the presence of preexisting heart disease.

Disruption in Thermoregulation and Metabolism

Elevated sympathetic discharge changes the temperature regulation set point in the hypothalamus, causing an inability to dissipate the internal body heat. Overproduction of sweat compensates for core cooling; however, rapid fluid loss immediately causes volume depletion.

Such a condition results in high metabolic rate, which increases the utilization of glycogen stores and proteolysis. If not controlled in high-humidity zones, hyperthermia will increase oxygen consumption in vital organs, lowering the threshold for brain excitation.

Standardized Assessment Tools

Clinical teams depend on clinically validated scores to continuously assess any physiologic changes. The Clinical Institute Withdrawal Assessment for Alcohol scale is used for assessment of pulse rate, anxiety, and trembling. 

The Clinical Opiate Withdrawal Scale measures pulse rate, pupil size, and joint pains. Lastly, there are benzodiazepine scales that assess motor instability and abrupt sensory shifts.

Medical Management and Clinical Interventions

Image Source: Gemini

Controlling autonomic instability requires stabilizing central neurotransmitters while softening peripheral sympathetic overload.

Clinicians use several core medical strategies to keep patients safe during detox.

  • Vital sign tracking with continuous monitoring equipment
  • Targeted medications to calm the central nervous system
  • Intravenous fluids to restore hydration and key electrolytes
  • Low sensory lighting to reduce external stress triggers

These combined interventions reduce physical discomfort and prevent dangerous shifts in blood pressure or rate. Continuous observation ensures that dangerous spikes in vital signs are caught immediately.

Pharmacological GABA-A Receptor Modulation

There is currently no pharmacological therapy other than agonism of GABA-A receptors that can counter the condition of central hyperarousal due to alcohol or sedative drug withdrawal. Long-acting benzodiazepines enable smooth and constant inhibition of CNS activity.

Through normalization of inhibitory function, they enable reduction in central noradrenergic firing in the locus coeruleus. This, in turn, ensures less stress on the cardiovascular system, a lack of muscle tremors, and virtually eliminates seizure risk.

Targeted Adrenergic Receptor Blockade

In situations where there is a lack of satisfactory control of autonomic symptoms by benzodiazepines, adrenergic-selective medications are also administered. Alpha-2 agonists achieve their effect by means of blocking presynaptic receptors within the brain in order to prevent excess release of norepinephrine.

In addition, clinicians may prescribe cardioselective beta-blockers for the management of chronic tachycardia and severe muscle tremors. These medications can help to ensure hemodynamic stability without producing excessive central sedation.

Hydration and Metabolic Functions

Dehydration happens when the body loses too much water and important minerals. A high metabolic rate makes this loss happen quickly. When someone gets IV hydration, it helps bring the body’s fluids to normal levels. This keeps the kidneys working and helps maintain steady blood pressure.

Magnesium and potassium need to be replenished to prevent any heart rhythm abnormalities due to high adrenaline levels. Thiamine should be administered in large doses to support carbohydrate metabolism.

Severe Complications of Unmanaged Withdrawal

The inability to manage autonomic hyperactivity can result in severe health complications. Generalized tonic-clonic seizures occur in many patients, where the brain continues to be out of control and overexcited.

According to statistics from the Substance Abuse and Mental Health Services Administration, up to 10% of patients undergoing severe withdrawal go through an abrupt autonomic crisis that needs immediate medical assistance. The local health departments report that timely admission into local detoxification centers in North Georgia significantly reduces overcrowding in the ER because of withdrawal complications.

Left untreated, patients may progress to severe confusion, high fever, and sudden circulatory failure. Furthermore, severe muscle agitation combined with extreme body heat can damage the kidneys and cause total organ collapse.

Delirium Tremens Pathophysiology

Delirium tremens is referred to as the most serious manifestation of an autonomic crisis. The signs that characterize the condition include confusion, hallucinations, be it visual or auditory, intense trembling, and unstable blood pressure. Dehydration and a high metabolic rate result in fast loss of bodily fluids and electrolytes. The process of IV hydration restores the fluid content of the body to its normal state, ensuring renal perfusion and stable blood pressure.

The reason for these symptoms is that the body releases hormones. This can cause blood pressure, a fast heart rate and a higher body temperature. Delirium tremens needs medical help. If not treated a person could die from problems, with the blood system or the breathing system.

Seizure Mechanisms and Excitotoxicity

Seizures associated with withdrawal manifest as acute generalized seizures resulting from excessive firing of glutamate neurons. The prolonged absence of GABAergic inhibition permits rapid propagation of electrical impulses in the cerebral cortical circuitry.

Each seizure increases cerebral oxygen use and cellular calcium uptake, resulting in cellular damage. It is important to prevent the occurrence of seizures to protect brain function.

Acute Kidney Injury and Rhabdomyolysis

Continuous motor agitation, muscle stiffness, and excessive heat production result in extensive breakdown of skeletal muscles. The breakdown of muscles results in the leakage of high amounts of myoglobin and potassium into the bloodstream.

High levels of myoglobin in the blood lead to clogging of the renal tubules, resulting in acute tubular necrosis. This eventually leads to the development of kidney failure.

Clinical Protocols for Long-Term Stabilization

Comprehensive treatment plans extend beyond immediate crisis management to ensure full physical recovery. Medical teams follow systematic protocols to guide patients safely through every phase of detox.

  • Tapering medication dosages gradually to prevent rebound symptoms
  • Reevaluating neurological function daily using standardized clinical criteria
  • Transitioning patients directly into structured residential or outpatient programs

Establishing these clinical steps minimizes physiological stress while preparing individuals for ongoing therapeutic care.

Clinical Protocol Standards for Managing Autonomic Instability

Proper withdrawal from drugs or alcohol requires regular supervision from the clinicians in order to manage such risks effectively. Clinician supervision enables continuous monitoring of vital signs, along with appropriate medication and treatment to prevent life-threatening complications.

Treatment centers provide an environment essential for managing complications and stabilizing patients according to their individual needs. Consulting the admission specialists at medically managed detoxification centers can help you make the right decision for recovery.

 

About the Author

Charles Schubert is a freelance marketer and SEO copywriter. He specializes in medical and wellness content. He has experience researching complex neurobiological mechanisms and healthcare protocols. Charles turns medical science into easy-to-understand practical resources. These resources help patients, families, and healthcare professionals make decisions.

 

References 

Bharadwaj, B., & Kattimani, S. (2013). Clinical management of alcohol withdrawal: A systematic review. Industrial Psychiatry Journal, 22(2), 100–104. https://doi.org/10.4103/0972-6748.132914

 

Romach, M. K., & Sellers, E. M. (1991). Management of the alcohol withdrawal syndrome. Annual Review of Medicine, 42(1), 323–340. https://www.annualreviews.org 

Please also review AIHCP’s Substance Abuse Practitioner Program and  CE courses to see if it meets your academic and professional goals.

Tools and Techniques for Establishing Trust in Virtual Therapy

Posted on by Joseph Gerard

MacBook Pro near white open book and coffee

Written by Kerem Okumus,

Now that virtual therapy seems to be becoming a common practice among therapists, there appears to be a question of establishing and maintaining a trusting relationship with patients.

It is much easier to establish trust and create a sense of intimacy during a face-to-face conversation than online. Nuances in body language, eye contact, and facial expressions can be easily missed or misinterpreted when communicating via a screen.

Moreover, you do not have the advantage of creating the right environment for sharing, e.g., using nice lighting, candles, or cushions for comfortable sitting.

It is much harder to create a comfortable environment when providing online therapy, but there are ways to do it successfully.

In this article, you will find some tips and tools that may help you create a peaceful atmosphere and develop trusting relationships with your patients. Hopefully, our guidelines will help you provide effective online counseling!

Creating a Truly Confidential Online Environment

Confidentiality is essential for the creation of a therapeutic alliance. Therefore, to establish trust, you should pay special attention to creating a safe environment in which the client knows that their privacy will be protected.

Platform Choice and End-to-End Encryption

The first thing to consider when choosing the platform for providing online therapy is the issue of the platform’s compliance with HIPAA.

Luckily, today there are many HIPAA-compliant teletherapy platforms that can help you with the provision of online therapy. Such platforms as Doxy.me, Zoom for Healthcare, and SimplePractice use end-to-end encryption that provides security.

Discussing the platform and its advantages and features can help you to create a safe environment.

Authenticated Access

Two-factor authentication (2FA) for the teletherapy account may be a very useful tool for improving the privacy of online therapy.

This method requires the user to complete an additional step of authorization (e.g., entering a verification code). Thus, even if the password was somehow stolen, the account will not be available to any third parties.

Privacy Tools to Protect Client Data

Along with the usage of a HIPAA-compliant platform, one more step that you may take to protect client data and create a confidential environment is the use of additional privacy tools.

If you conduct online therapy or receive any sensitive information on the computer, using a VPN service for PC can be helpful for protecting your internet connection from any interceptions.

Using general privacy tools can be an additional measure that will help you to create a more protected online environment.

Therapeutic Alliance: Tips for Creating Rapport Online

The success of therapy is often dependent on the therapeutic alliance that a therapist creates with his or her patient. Moreover, in order to create such an alliance, therapists spend a lot of time.

In the era of virtual therapy, when more than half of sessions are conducted remotely (either online or over the phone), creating a rapport without meeting patients face-to-face takes even more effort.

So, what may be helpful in such cases?

Being Verbal and Listening Actively

Every therapist knows that active listening is essential for the process of therapy. However, in-person interaction gives us the opportunity to read the client’s nonverbal signs and react to them. In the case of virtual therapy, these nuances can be missed.

Thus, being verbal and listening actively becomes more important in the case of virtual therapy. Tone, pauses, and choice of words become more significant in the process of communication. The demonstration of your engagement also becomes more important.

The repetition of the client’s words or the summarization of what he or she said can be very helpful in demonstrating that you are really paying attention to him or her.

Such words as “I hear you” or “that makes sense” can also be very useful in the case of virtual therapy to help the client realize that he or she is understood.

Nonverbal Communication

Establishing eye contact is another important thing to build trust with the client, but it becomes harder in the case of virtual therapy. Nevertheless, there are some things you can try.

For instance, positioning your camera at eye level can help you in the process of communication, as well as being visually present and engaging.

Not every client can feel comfortable being on camera, and it should be respected, but, nevertheless, video and audio can help in the process of creating rapport.

Some platforms, such as Zoom, have the “hide self view” option so that the client does not see himself or herself but still sees you. At the same time, you can still see him or her.

In the case of virtual therapy, the more expressive you are, the better. Some subtle cues cannot be easily understood by clients during the process of virtual therapy; thus, being more engaged and expressive, and using some nonverbal cues such as hand gestures can be very useful.

Setting Expectations and Boundaries

Talking about boundaries, the duration of the session, and the expected response time can be helpful in creating the right environment. In addition, it is important to discuss the confidentiality of the communication and protection of the client’s personal data.

It may also be helpful to have a simple backup plan so that you both know what to do in case of any problems with the connection or platform.

Conclusion

Providing therapy online definitely changes the way of building trust but makes it no less possible. It is just necessary to be more thoughtful and purposeful in the way you are communicating and creating a safe environment for your client.

Even small things become more important in the virtual environment. How you listen, how you react, how present you look, and how clearly you handle the issue of confidentiality all influence the feeling of your client about the safety of the environment.

About the author

Kerem Okumus is an Outreach Executive at Intseo Media, where he focuses on SEO outreach, publisher communication, and digital content partnerships. He has experience working with content covering technology, online privacy, cybersecurity, and other digital topics. 

 

 

 

Please also review AIHCP’s Grief Counselor Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

How To Evaluate Evidence Behind Dietary Supplement Claims

Posted on by Joseph Gerard

Stethoscope next to herbs and flowers.

Written by Marko,

The rise in wellness has, without question, contributed to the rise in popularity of various dietary supplements. Much more than ever before. However, the question of their effectiveness is another matter. A matter that most healthcare professionals have been asked and/or consulted by patients. Questions such as whether a particular ingredient is worth considering, whether a product’s claims are supported by research, or how to compare two supplements that appear to offer similar benefits.

Answering these questions is a little bit more complicated. 

There are a lot of elements to factor in, and research findings may not necessarily apply equally to every product or every person/individual. It’s a difficult matter to quantify and ‘calculate’ accurately and with a high degree of certainty.

The evidence is all over the place. 

A study can be scientifically legitimate while still providing limited support for a particular claim about a particular supplement. The question is how nurses and other healthcare professionals should develop a structured approach toward evaluating this evidence and help consumers understand what all the available research does and (more importantly) doesn’t support.

Start With the Exact Ingredient

One approach is focusing on a single ingredient. It does sound a bit obvious thinking about it, but talking about a single ingredient is not the same as talking about a product that is a combination of various ingredients. 

Even a similar product (one that shares the same ingredients as the other in question) can be different, for example, magnesium. 

We have magnesium citrate, magnesium glycinate, Magnesium oxide, and Magnesium chloride. They’re all sources of magnesium, but they are not interchangeable in every respect. They are different forms/compounds that provide magnesium and have different chemical properties, solubility, absorption, and tolerability. Of course, because of these differences, research involving one form shouldn’t automatically be assumed to apply equally to another.

Then there’s the form an ingredient has, another important factor to take into account. 

Research may involve a particular preparation, concentration, combination, or amount that differs from what is found in a commercially available supplement. A reference to one substance doesn’t establish evidence for another due to their names being similar or even their functions.

But it’s not just the product(s) and the research on those same ones, but it is also HOW the research is being conducted that needs to be factored into this equation. Just because you found one research paper that confirms a specific claim, it matters what the parameters and methods were that were used in the said research to get those results.

Because of this, factors that are worth considering here are:

  • The exact ingredient that has been used
  • Its form or formulation
  • The amount that has been used in the making of the product
  • The intended conditions of use of the product
  • The population that has been studied (and the sample size)
  • The duration of the use of the product

The closer the studied ingredient, formulation, amount, conditions of use, population, etc., are to those of the product that’s being currently evaluated, the more (directly) relevant the research may be. But with that being said, just pure similarity between two (or more) products doesn’t by itself mean/establish that findings from that one precut automatically apply to the other one; nor does this substantiate a specific benefit claim.

In laymen’s terms, a specific product may make a specific claim that’s directly supported by research relevant to that same product. Now, if you take a different product that has similar (or even the same) ingredients, that doesn’t necessarily mean that the research from the first product also backs a specific claim for the second product.

When comparing similar products, such as when consumers browse peptide bioregulator products, their formulation and amount should be compared carefully when you’re trying to assess whether particular research is relevant here. The presence of similar ingredients alone SHOULD NEVER be interpreted as evidence that the products will offer the same (or even similar) effects.

NOTE: Two products can contain an ingredient with the same general name while completely differing in formulation and amount.

What Is the Type of Evidence You’re Looking At

There are different types of evidence, or more precisely, not every study answers all the questions. 

For example, human studies generally provide more directly relevant information about how an ingredient performs in people compared to that of laboratory or animal research. However, that does not mean that their results should be taken for granted. Some controlled human studies may provide information that is useful concerning a specific outcome when under defined conditions. On the other hand, an observational study may identify an association without establishing that one factor caused the other.

Then, if we take Animal research, we can find that it contributes to a specific scientific understanding, but findings from animal research cannot be assumed to have the same effect in humans.

There’s a lot to it, and because of this, healthcare professionals should generally avoid treating all citations as interchangeable. 

After all, it is clear to most people that just because a certain product has a great website with lots of amazing references, it doesn’t mean that those same references/sources adequately substantiate specific claims that are being made.

Steps That Could Lead To A Clearer Picture

Reading a study’s abstract can be a good starting point. 

Unfortunately, that does not always provide enough information for a precise and proper evaluation of evidence. Health professionals who want to better understand how informative a study really is should consider different factors.

  1. Review The Population Used in The Study

Who participated in the study?

Age, sex, health status, lifestyle, and other characteristics that are relevant to the study.

A narrow group has only narrow implications, ones not applicable to a general wider population.

  1. Take Sample Size into Account

Sample size is a key factor in any study. If a study has been done using a small sample size, then although that number of participants could potentially provide useful preliminary information, the study still needs confirmation via additional research.

NOTE: A larger sample size does not automatically make it better or true; there are, after all, a lot of factors to include, such as its design or methodology that was used. Also, the limitations that were present.

  1. Study Design

Another question to ask is how the study was conducted.

While controlled and randomized studies can provide various types of information, understanding the design greatly helps when determining whether the conclusion that was made is one that was reasonably drawn from the given results.

  1. The Duration of the Study

Not every study can fit in an equal timeframe. Some require more time; others less. However, generally speaking, a short study can provide information when it concerns short-term outcomes, but it will most likely never answer questions that pertain to long-term use.

  1. The Outcome

What did researchers actually measure?

This is a question that needs to be asked when evaluating any claim, including a supplement claim. 

One study may look for a specific biological marker, for example, while promotional material can present the findings as evidence for a much broader benefit. In this case, the measured outcome and the marketed claim are not the same thing, or at least not necessarily the same thing. 

This is an important distinction to keep in mind.

Does the Evidence Actually Support the Claim?

One of the most important distinctions for healthcare professionals to understand is whether the evidence actually supports the claims.

To understand this, the evidence needs to be evaluated against the specific claim. Those claims are as follows:

  • What did the researchers actually find?
  • Was the finding statistically meaningful?
  • Was it clinically or practically meaningful?
  • Was the outcome measured directly?
  • Was the study designed to evaluate the claim being made?
  • Were the researchers studying the same ingredient and formulation?
  • Were the participants representative of the intended population?

The conclusion should remain within the boundaries of what the evidence actually supports rather than extending beyond it.

Another thing is that wording matters, and it must be precise. Even a small change in the language can change the consumer’s understanding of the product. It is important for it to be truthful, not misleading, and appropriately substantiated.

Conclusion

A scientific paper or a familiar ingredient aren’t good enough bases for evaluating specific dietary supplement claims. 

Both the relevance and the quality of all the evidence gained from various studies matter. Any healthcare professional should carefully evaluate all the available evidence pertaining to specific products such as the exact ingredient, formulation, amount, population, study design, measured outcomes, and consistency of the available evidence. And possibly even more than that.

It is, without a doubt, a complicated matter that poses more questions than answers, but despite that challenge, a thoughtful and evidence-focused approach will allow healthcare professionals to provide consumers with a useful context, including realistic expectations within the best of their ability; one that they can say with confidence.

2 Interlinking Opportunities:

From https://aihcp.net/2026/07/23/why-healthcare-professionals-should-follow-peptide-research/ with anchor peptide research

From https://aihcp.net/2025/03/14/unlocking-the-impact-of-ethical-research-through-online-doctoral-education/ with anchor aspiring researchers

Author Bio 

Marko is an adamant and eager content writer with a decade of experience in various niches,  with healthcare being one of them. With his way of implementing storytelling, comparisons, and examples into hard-to-grasp topics, Marko’s able to make complex things sound interesting and relatable – key ingredients to make something understandable. As a hobby, Marko enjoys offroading, board games, and spending time with his family and his dog Cezar.

 

 

Please also review AIHCP’s Holistic Nursing Certification program and Nurse Courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

How to Specialize in Grief Counseling for Life-Altering Injuries 

Posted on by Joseph Gerard

Sad woman in a wheelchair suffering with grief. Written by Deepika,

Grief is a complex process, one that involves some type of loss in most cases. Not everyone possesses the internal resources needed to deal with overwhelming or crippling grief. While this emphasizes the demand for grief counselors, it’s important to understand that their role is not confined to a box. 

Many people only think of bereavement when a major loss is discussed. What about a life-altering injury that can leave someone grieving abilities they once had, a career they valued, or a future they had dreamt of? These losses can be just as important to address as the physical effects of the injury. 

Healthcare professionals interested in this area can specialize in grief counseling to support patients through a part of recovery that medical treatment may not suffice for. This article explains how to prepare for a specialization in grief counseling to support people after catastrophic injuries. 

Understand How Grief Works When Life is Forever Changed by Injury 

The first thing about injury that every healthcare professional must understand is that it is not always the same. As the Loewy Law Firm notes, a catastrophic injury causes permanent damage to the body and makes the victim unable to return to their former life or work. 

What differentiates a catastrophic injury from other kinds is the duration and the intensity of medical care required. Here, instead of losing another person, the individual may be coming to terms with changes in their body, abilities, independence, or the future. Such losses can continue to affect them long after the initial injury and medical treatment. 

At the heart of it, a patient may be grieving several changes at the same time, including:

  • The loss of mobility, strength, coordination, and other physical abilities
  • The need to seek help with activities that were previously normal or private 
  • Being unable to return to a former career or support themselves in the same way 
  • An unexpected change in responsibilities and relationships because of the injury 
  • The internal struggle with changes in appearance or the roles that once shaped their sense of self 
  • Having to reconsider plans or goals that once seemed achievable 

The reason such injuries are called life-altering is that their physical and emotional effects are severe. A 2025 study of people with moderate-to-serious brain injuries found that almost half of the participants continued to experience symptoms of anxiety/depression eight years after their injury. 

Moreover, difficulty dealing with the effects of the injury was also associated with higher emotional distress and poorer quality of life. Family and friends can provide valuable support, but they may not know how to deal with the situation. Motivating a patient to ‘stay positive’ or focus only on physical health leaves no room to process their loss. 

For healthcare professionals counseling victims of catastrophic injuries, this means looking beyond the immediate physical consequences of the injury. A counselor also needs to help clients express difficult emotions, work through changes in identity, and understand how their losses are affecting their relationships/future. 

 

Build the Skills to Guide Others Through Grief 

A general understanding of grief is not enough to counsel someone after a life-altering injury. There are several things patients often deal with at once, including physical disabilities, family responsibilities, changes in work, and plans for the future. 

A counselor must be able to understand such different concerns without assuming that every patient experiences them in the same way. So, what are some important skills professionals interested in becoming a grief counselor for catastrophic injuries must develop? They include the following:

  • Active listening, as patients require time and room to open up about their difficult experiences and emotions 
  • Empathy without reservations, as two people with similar injuries may grieve very differently 
  • Trauma-aware communication, where calm, respectful language is used without any pressure on patients to discuss their painful experiences 
  • Respect for independence, as patients need opportunities to make choices wherever possible to retain a sense of control 
  • Awareness of serious emotional concerns, since counselors must recognize when grief may occur alongside major depression, anxiety, or thoughts of self-harm 

A 2026 CBS News report showed how recovery can continue long after the initial injury. It shared the story of Hannah Strom, who survived a 2020 crash that injured 10 students and their coach. The incident left her with a broken leg and pelvis, a collapsed lung, and a traumatic brain injury (TBI). Over six years later, she was working as a rehabilitation aide at the same hospital where she had recovered. 

The report also highlighted the importance of looking beyond the immediate treatment of a serious injury. From the outside-in, a bird’s-eye view would suggest the need to prevent such injuries in the first place. 

Joseph Nugent, a fourth-year resident neurosurgeon at Oregon Health and Science University and a former paramedic, said, “When I was a paramedic, I brought countless patients to the hospital with traumatic brain injuries.”

He continued, “Skilled neurosurgeons can accomplish a lot, but my fire department and public health mentors showed me the best way to optimize outcomes for trauma is to direct efforts toward preventing the injury in the first place.” Indeed, prevention and grief counseling address different parts of the recovery process, but the crux is to extend care beyond the immediate injury. 

Finally, one cannot neglect the limits of grief counseling. Some patients may require assessment or treatment from another qualified mental health professional, especially when emotional challenges become severe. Even then, knowing when to involve others from the care team is an important part of preparing for this specialization. 

 

Lay the Groundwork for a Counseling Specialization 

Once you know your interest is in the area of grief counseling for life-altering injuries, it’s time to materialize that interest. What this means is that professionals need a strong foundation in grief, counseling, trauma, and the way serious injuries affect a person’s daily life and sense of self. 

The right preparation will depend on your existing healthcare background and professional goals. For instance American Institute of Health Care Professionals (AIHCP) has been offering grief counseling certification and CE courses in grief/bereavement for over 25 years. Receiving specialized continuing education and certification is a great way to increase your knowledge and lay the groundwork for your own grief practice. 

Be mindful that even college level healthcare training may not always give you the extensive knowledge/experience you need for dealing with grief. A 2026 exploratory survey of US medical schools found that, among the 10 schools that responded, 60% devoted fewer than five hours to teaching students how to cope with grief. Where as a certification with AIHCP is worth 100 continuing education hours.  

What’s more, 60% did not formally include physician grieving or coping in their curriculum. Only 20% reported offering specific clinical experiences involving end-of-life care during the preclinical years. Now, the survey had a low response rate, so it cannot be treated as representative of every US medical school. 

However, the findings make it clear that general healthcare experience does not always provide all the specialized knowledge needed to support people through a major loss. Deliberation on your part is a must. Therefore, consider preparing in the following ways:

  • Familiarize yourself with how people cope with different forms of loss. 
  • Strengthen your ability to listen attentively, ask useful questions, and communicate with empathy. 
  • Learn how traumatic experiences can affect emotions, behavior, relationships, and a person’s ability to recover after an injury. 
  • Understand the different types of complex grief responses. 
  • Develop a clear understanding of confidentiality, informed consent, and professional boundaries. 
  • Look into the emotional demands of working with people experiencing grief and how they may affect your ability to provide care. 

It is equally helpful to connect your grief counseling education with the type of injuries you may encounter. For example, someone working with people who have traumatic brain injuries may benefit from learning more about cognitive and behavioral changes. Similarly, those likely to work with people experiencing spinal cord injuries may require a deep understanding of changes in mobility and daily living. 

Gain relevant practical experience by exposing yourself to rehabilitation settings, hospitals, support groups, and community services. No matter the course you choose, do not forget to earn a proper license, especially when your role demands it. 

 

Join Hands With the Patient’s Wider Circle of Care 

The process of recovering from any sort of trauma is so complex that it cannot happen in a vacuum. Patients often have to work with physical therapists, social workers, rehabilitation specialists, and other healthcare professionals. If you plan to specialize in this area, it’s vital to understand how a host of professionals contribute to recovery. 

That’s the key to knowing where grief counseling fits into the big picture. Let’s consider a 2025 study that analyzed data from 79,604 people with moderate-to-severe traumatic brain injuries in the US Traumatic Brain Injury Model Systems database. Researchers compared 4,620 people who began rehabilitation early with 2,722 who joined much later. 

Earlier rehabilitation was found to be associated with improvements in productivity and life satisfaction. The latter included aspects like regaining independence, rebuilding relationships, and participating in daily activities. As you prepare for the specialization of grief counseling, learn to understand where your role stands amid the work of other professionals. 

Here’s an example: A patient who gets frustrated with rehabilitation may need a physical therapist to address a functional problem. At the same time, a counselor can help the patient work through the grief and frustration surrounding that limitation. Once you develop an understanding of how everything is interconnected, it will help you in the following ways:

  • You will know the role and contribution of each healthcare provider in the patient’s recovery. 
  • It becomes easier to understand the patient’s goals, such as what they wish to accomplish for themselves. 
  • Communication becomes smoother as you learn to share information between team members while preserving patient privacy. 
  • The changing needs of the patient are easier to spot, which may shift from surviving the injury to dealing with relationships or their future expectations. 

 

FAQs 

What does a grief counselor do for someone with a life-altering injury? 

A grief counselor helps patients process losses related to independence, abilities, relationships, work, identity, and future plans. They provide emotional support, help patients understand their changing circumstances, and recognize when additional mental health care or support may be needed. 

What skills are required to counsel people after catastrophic injuries? 

Important skills include active listening, empathy, respect for patient independence, trauma-aware communication, and asking thoughtful questions. Professionals should also understand grief, trauma, professional boundaries, and how emotional challenges affect recovery. 

What preparation is needed to work with patients experiencing injury-related grief? 

Preparation to work with patients experiencing injury-related grief may include education in grief and counseling, trauma awareness, relevant healthcare knowledge, practical experience, and ongoing professional development. Professionals must also understand their licensing requirements and learn how to work with a multidisciplinary care team. 

 

Key Data Points to Consider 

2025 study of people with moderate-to-severe acquired brain injuries  Almost half of the participants continued to experience symptoms of anxiety/depression eight years after their injury. 
2026 exploratory survey of US medical schools 
  • 60% devoted fewer than five hours to teaching students how to cope with grief. 
  • 60% did not formally include physician grieving or coping in their curriculum. 
  • Only 20% reported offering specific clinical experiences involving end-of-life care during preclinical years. 
2025 analysis examining 65 studies for group-based psychosocial interventions for adults with acquired brain injury The meta-analysis of 48 studies involving 2,653 participants found a small but statistically significant improvement in psychosocial outcomes. The outcomes considered were anxiety, depression, emotional distress, quality of life, and social support. 

Healthcare professionals cannot afford to rip apart the emotional and social aspects of recovery after a catastrophic injury. A 2025 analysis examined 65 studies for group-based psychosocial interventions for adults with acquired brain injury. In the meta-analysis, 48 studies involving 2,653 participants were included. 

The review discovered a small but statistically significant improvement in psychosocial outcomes. The outcomes that were examined included anxiety, depression, emotional distress, quality of life, and social support. Now, this does not mean that a single counseling approach will work for every patient. 

However, it does bring our original exploration full circle: recovery has to do with more than the immediate injury. So, your goal is not just to help someone feel better about what happened. It is to support them in working through the losses and discovering new ways to participate in family life, work, relationships, and the community. 

References 

  1. Lgoe Anna et al. 2025. Psychological outcomes following moderate-to-severe acquired brain injury: A longitudinal study. PubMed. 

https://pubmed.ncbi.nlm.nih.gov/40521926/

  1. Robinson, Erik. August 2026. Causes of traumatic brain injury vary widely worldwide, study finds. Oregon Health and Science University. 

https://news.ohsu.edu/2026/08/19/causes-of-traumatic-brain-injury-vary-widely-worldwide-study-finds

  1. Vishwanath Vineet, Plummer M Maria, et al. March 2026. Grief and coping education in US preclinical medical curricula. Findings from an exploratory survey. PubMed Central. 

https://pmc.ncbi.nlm.nih.gov/articles/PMC13039567/

  1. Thomson Kate, Haslam Catherine, et al. August 2025. Group Psychosocial Interventions Following Acquired Brain Injury: A Systematic Review and Meta-analysis of Group Process and Outcomes. Springer Nature Link. 

https://link.springer.com/article/10.1007/s11065-025-09670-w

Author Bio

Deepika has over six years of experience as a writer and editor. Passionate about words and learning, she takes an interest in a variety of niches. Her knack for turning complex ideas into relatable narratives allows her to resonate with the reader. When her pen falls silent, you can find her engrossed in a novel or getting her hands messy with fine arts. Through these, Deepika is committed to keeping her curiosity and creativity alive. 

 

 

Please also review AIHCP’s Grief Counselor Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

What Is Role Based Access in Healthcare IT

Posted on by Joseph Gerard

a stethoscope is on the keyboard of a computer. allocation and organization of doctors.Written by Veronica Turner,

A nurse does not need the same system access as a pharmacist, and a billing specialist should not be able to browse a patient’s full clinical record simply because both work for the same hospital. Role based access control, or RBAC, turns that basic idea into a practical security framework.

In healthcare IT, RBAC gives people access according to their jobs and responsibilities rather than handing every authorized user the same permissions. Done well, it protects sensitive information without putting unnecessary barriers between clinicians and the data they need to care for patients.

What Is Role Based Access in Healthcare IT

Role based access control assigns system permissions to defined roles and then assigns users to those roles. Instead of configuring every employee individually, an organization might create access profiles for emergency physicians, registered nurses, pharmacists, billing staff, residents, and IT administrators.

That distinction matters in a hospital where thousands of people may interact with dozens of applications. According to HHS, the HIPAA Security Rule requires regulated organizations to authorize access to electronic protected health information when that access is appropriate for the user’s role.

RBAC gives healthcare organizations a manageable way to put that principle into everyday practice. Someone’s badge may get them through the hospital door, but their digital role determines which electronic doors open after they sign in.

Roles Should Reflect Actual Clinical Work

The difficult part is defining roles closely enough to match real workflows. Giving every physician identical permissions sounds simple, but an attending physician, radiologist, resident, and locum tenens physician may have different responsibilities.

Effective RBAC therefore starts with understanding how people actually work. Healthcare IT, security, compliance, and clinical leaders may need to collaborate so permissions support patient care rather than merely reflecting job titles on an organizational chart.

RBAC And Least Privilege Work Together

RBAC determines which permissions belong to a role, while least privilege guides how broad those permissions should be. Under least privilege, users receive the minimum access reasonably necessary to perform their responsibilities.

Consider a scheduler who needs demographic and appointment information but does not need unrestricted access to clinical notes. RBAC can create the scheduler role, while least privilege keeps unnecessary clinical permissions out of it.

A practical access design commonly considers several questions:

  • What information does this role genuinely need
  • Which systems should the role access
  • How long should those permissions remain active

Those questions become especially valuable when roles change. A nurse moving into management, for example, should not automatically retain every permission from a previous clinical assignment simply because nobody removed it.

RBAC And ABAC Solve Different Problems

Role based access is effective when permissions map cleanly to predictable jobs. Attribute based access control, or ABAC, goes further by evaluating characteristics surrounding a particular access request.

Those attributes might include department, location, device, time, patient relationship, or assignment status. A physician could have the correct professional role yet still face restrictions because the patient is outside the physician’s current care relationship.

ABAC can therefore handle context that a broad role may miss. Healthcare organizations can also combine approaches, using RBAC for baseline permissions and additional contextual controls where clinical circumstances require finer decisions.

On Call Work Creates An Important Test

Healthcare does not operate on a predictable nine-to-five schedule. An on-call physician may suddenly need records that would normally fall outside a routine assignment, while covering clinicians may temporarily assume responsibilities belonging to another team.

Access policies need a controlled method for accommodating those situations without permanently expanding someone’s permissions. Time-limited access, documented approvals, contextual rules, and audit logging can help organizations distinguish legitimate exceptions from excessive standing access.

Break Glass Controls Handle Genuine Exceptions

Sometimes normal permissions cannot anticipate an urgent clinical need. Break-glass functionality can provide exceptional access when delaying care to obtain routine authorization would be inappropriate.

The important word is exceptional. A break-glass mechanism should not become a convenient shortcut around ordinary access rules, and organizations can require users to provide a reason while recording the event for later review.

The American Medical Association has also highlighted an important nuance: HIPAA does not specifically require healthcare organizations to apply universal restrictive break-glass functionality to employee patient records. Organizations need to balance privacy controls with the possibility that unnecessarily restrictive workflows could interfere with legitimate treatment.

Audit Trails Make Exceptions Accountable

Emergency access becomes safer when it leaves a meaningful record. Security teams should be able to determine who accessed information, when access occurred, what was accessed, and whether an exception mechanism was invoked.

Review matters just as much as collection. An untouched access log offers little protection, while monitored records can help security and privacy teams identify unusual patterns and investigate questionable activity before it becomes an accepted habit.

Credential Lifecycles Matter As Much As Roles

Access control does not end when an account is created. Healthcare workforces constantly change as employees transfer departments, clinicians gain privileges, residents rotate through services, contractors finish projects, and temporary physicians complete assignments.

HHS’s Healthcare And Public Health Cybersecurity Performance Goals identify unique credentials and credential revocation among essential cybersecurity goals. For healthcare teams, that means knowing who owns each account and promptly changing access when the person’s relationship with the organization changes.

A well-managed credential lifecycle covers provisioning, modification, review, and removal. Connecting those stages to human resources, medical staff, residency, and contractor processes can reduce the chance that forgotten permissions remain available after their legitimate purpose disappears.

Password Handling Still Deserves Attention

RBAC controls what an authenticated account can reach, but it cannot compensate for careless credential handling. Shared passwords and reused credentials make individual accountability harder and can weaken otherwise thoughtful access controls.

When staff legitimately manage multiple credentials, secure storage provides a more sensible alternative to recycling memorable passwords. Bitdefender frequently appears in expert roundups of the best password manager solutions, offering an example of how unique login credentials can be securely stored and organized rather than reused.

Healthcare organizations should still follow their own approved technology, credential, and device policies. Password management supports RBAC when each account remains attributable to a specific authorized person instead of becoming an informal shared doorway into protected systems.

Rotating Residents And Locum Tenens Need Special Attention

Temporary clinical assignments expose one of RBAC’s biggest operational challenges. A locum tenens physician may require substantial privileges immediately but need them removed just as quickly when an assignment ends.

Residents create similar movement as they rotate between services and facilities. Their clinical responsibilities can change several times during training, so an access profile that was appropriate last month may be excessive during the next rotation.

Automation can help tie account changes to authoritative workforce and scheduling information, but organizations still need clear ownership. Someone must be responsible for confirming when temporary access begins, when it changes, and when it expires.

Cross Organizational Access Adds Complexity

Clinicians increasingly encounter information that crosses organizational boundaries. A 2025 scoping review of healthcare professionals’ EHR access found that cross-organizational access involves considerations including information quality, training, and trust among healthcare providers.

For the people managing access, this means a valid clinical identity alone may not answer every authorization question. The organization also needs to understand the person’s current relationship to the patient, facility, and specific care activity.

Periodic Reviews Keep Role Based Access Accurate

Even a carefully designed RBAC program becomes outdated. Departments reorganize, applications gain new features, responsibilities evolve, and users accumulate permissions as they move between positions.

Periodic access reviews give managers, system owners, security teams, and compliance staff an opportunity to ask whether current permissions still make sense. High-risk systems and privileged accounts may justify more frequent attention than low-risk tools.

Reviews should also examine the roles themselves, not only the people assigned to them. If almost everyone repeatedly needs exceptions, the underlying role may be poorly designed; if a role contains permissions nobody uses, it may be broader than necessary.

Evidence from those reviews can also support compliance and accreditation efforts. Documented approvals, removals, exception records, and review histories show that access management is an ongoing governance process rather than a policy sitting untouched in a binder.

Stronger Role Based Access Supports Safer Healthcare

Role based access works best when healthcare organizations treat it as a living system. Roles establish sensible starting permissions, least privilege limits unnecessary access, contextual controls address unusual situations, and break-glass processes provide an accountable route through genuine emergencies.

Credential lifecycle practices and periodic reviews complete the picture by keeping permissions aligned as people move through the organization. This approach makes role based access practical for complex workforces that include permanent clinicians, residents, temporary staff, contractors, and on-call teams.

For healthcare leaders reviewing their own security practices, a useful next move is to compare current permissions with the work people actually perform. AIHCP readers can explore relevant professional education and healthcare resources on the site’s service pages, then consider where their own organizations could tighten access without creating new obstacles to patient care.

Small access improvements today can prevent much larger problems tomorrow. 

Author Bio: Veronica Turner is a health and lifestyle writer with over 10 years of experience. She creates compelling content on nutrition, fitness, mental health, and overall wellness.

 

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Personalized Healthcare: Why One-Size-Fits-All Treatment Approaches May Fall Short

Posted on by Joseph Gerard

Cartoon laptop with medical symbols from varying fields of medicine on it.

Written by Amanda Collins,

For most of modern medical history, treatment has been built around the average patient. Clinical trials enroll a defined population, researchers measure how that population responds to a drug or intervention, and the results become the basis for guidelines that are then applied broadly. This approach has produced enormous public health gains, but it has an inherent limitation: no single patient is actually “average.” As healthcare professionals increasingly recognize, the gap between population-level evidence and individual patient response is where a great deal of ineffective, and sometimes harmful, care originates. Personalized, or precision, medicine is the growing effort to close that gap.

The Problem with Standardized Treatment

Clinical guidelines are, by design, statistical summaries. A dosing recommendation or first-line therapy is typically the option that performed best on average across a trial population. But “best on average” can obscure enormous variation underneath. A medication that produces strong benefit in the majority of trial participants may be ineffective, or even harmful, in a meaningful minority. Genetics, metabolism, body composition, comorbid conditions, and lifestyle factors all influence how an individual actually responds to a given intervention, yet standardized protocols often cannot account for all of these variables at the point of care.

Guidelines still serve an essential purpose: they give clinicians a defensible, evidence-based starting point, and quality-of-care frameworks like those taught in health care quality management certification programs exist precisely to help systems balance consistency with outcomes. But a starting point is not a finish line, and treating it as one is where standardization tends to fail patients.

This is part of why interest in individualized health optimization has grown well beyond the prescription pad. Patients are increasingly proactive about supporting their own physiology based on their personal biomarkers and goals, whether that means requesting more detailed lab panels or exploring targeted nutritional support such as premium NMN supplements, which some patients pursue as part of a broader, individualized approach to cellular energy metabolism and healthy aging. The larger point clinicians should take from this trend is not about any one product category. It’s that patients themselves are already thinking about their care in more personalized terms than the standard treatment model typically offers.

The consequences of ignoring this variability are not trivial. In the case of pharmaceuticals, adverse drug reactions are estimated to be the fourth leading cause of death in the United States, contributing to roughly 128,000 deaths and $136 billion in costs annually, a burden larger than the total cost of cardiovascular or diabetes care.

A meaningful share of that burden traces back to treatment decisions made for the “average” patient rather than the one actually sitting in the exam room.

Why People Respond Differently

The biological basis for variable treatment response is well established. Pharmacogenomics, the study of how genetic variation affects drug metabolism, has shown that genetic factors alone can account for anywhere from 20% to 95% of the variability seen in drug response, depending on the medication and condition involved.

 Variants in genes encoding cytochrome P450 enzymes, for example, determine whether a patient metabolizes a given drug quickly, slowly, or not at all, directly affecting both efficacy and the risk of toxicity.

Genetics is only one piece of the puzzle. Body composition and age change how drugs distribute and clear from the body. Pre-existing conditions can alter organ function in ways that affect dosing safety margins. And a newer area of research, sometimes called pharmacomicrobiomics, has demonstrated that differences in gut microbiome composition can meaningfully influence drug absorption and metabolism, adding yet another layer of individual variability that standard protocols rarely capture.

Taken together, these factors explain why two patients with the same diagnosis, given the same medication at the same dose, can have entirely different outcomes.

Where This Shows Up in Practice

These effects are not theoretical: they show up across common areas of clinical care:

Antidepressant prescribing is a frequently cited example of trial-and-error medicine. In the landmark STAR*D trial, only about a third of patients achieved remission on their first antidepressant, with response rates dropping further at each subsequent treatment step.

Much of this variability is now understood to relate to genetic differences in how patients metabolize SSRIs and other psychiatric medications, which is why pharmacogenomic testing prior to prescribing is gaining traction in psychiatric practice.

Statin response varies considerably as well. Some patients achieve significant LDL reduction on a standard dose, while others see minimal benefit or experience side effects such as myopathy, often tied to genetic differences in drug transport and metabolism.

Cancer treatment has arguably moved furthest toward personalization. Tumor genomic profiling now routinely informs chemotherapy selection, allowing oncologists to match specific targeted therapies to the molecular characteristics of a patient’s tumor rather than relying solely on cancer type and stage. A related example is clopidogrel therapy in cardiovascular medicine, where genetic variation in the CYP2C19 gene means up to 30% of patients treated for acute coronary syndrome show a poor response to the standard regimen, with heritability accounting for the majority of that variability.<sup>6</sup>

Diabetes management protocols illustrate a different kind of mismatch, not pharmacogenomic, but behavioral. Standardized dietary and medication regimens frequently fail to account for a patient’s work schedule, food access, cultural food practices, or comorbid conditions, all of which affect whether a plan is actually sustainable.

What Personalized Care Looks Like Instead

Precision medicine does not mean discarding evidence-based guidelines; it means using them as a starting point rather than a final answer, then adjusting based on the individual in front of the clinician. In practice, this looks like several concrete shifts in care delivery:

  • Genetic testing before prescribing, particularly for drug classes with well-documented pharmacogenomic variability, such as certain antidepressants, antiplatelet agents, and chemotherapy drugs.
  • Biomarker-driven treatment planning, using more thorough bloodwork and diagnostic panels to guide decisions rather than defaulting to standard dosing based on age and weight alone.
  • Lifestyle-integrated care plans that account for a patient’s actual daily routine, occupation, and support system, rather than assuming a uniform capacity to follow a rigid protocol.
  • Clinician-led assessment over protocol-driven defaults, restoring the physician’s judgment as the final filter through which population-level guidelines are applied to a specific patient. This is also where case management plays an underappreciated role: professionals trained through programs like AIHCP’s case management certification are often the ones coordinating across specialists, translating biomarker-driven plans into something a patient can actually follow day to day.

This shift is also visible in the growth of specialized, condition-focused clinics that build their entire care model around individualized assessment rather than generic primary care visits. Men’s health has become a particularly active area for this kind of specialization, with dedicated practices offering in-depth hormone panels, metabolic testing, and tailored treatment plans that a standard 15-minute appointment often cannot accommodate. A patient in the Midwest, for instance, might seek out a men’s health clinic in St. Louis specifically because it offers more comprehensive, individualized diagnostic workups for concerns like low testosterone, fatigue, or metabolic changes than a general practice visit typically allows. This trend reflects a broader consumer expectation: patients want their care to be built around their specific physiology, not a generic template.

The Role of Technology

Much of what makes personalized care more feasible today than it was a decade ago comes down to technology. Direct-to-consumer and clinician-ordered genetic testing has become dramatically more affordable, making pharmacogenomic screening realistic for routine use rather than a specialty-only tool. Telehealth platforms have expanded access to specialists who can interpret complex biomarker data, particularly for patients outside major metropolitan areas. Wearable devices and continuous monitoring tools now generate real-time physiological data (glucose trends, heart rate variability, sleep architecture) that can inform treatment adjustments far more responsively than periodic office visits alone.

Electronic health records with integrated clinical decision support are also beginning to flag gene-drug interactions automatically, reducing the burden on clinicians to remember every relevant pharmacogenomic interaction. Collectively, these tools are lowering the cost and complexity of individualized assessment, moving precision medicine from a resource reserved for academic medical centers toward something achievable in routine practice.

Takeaway

Personalized medicine is not about adding complexity for its own sake, nor is it a rejection of the clinical trial evidence that underlies modern medical guidelines. It is about recognizing that guidelines describe an average patient who does not exist in any single exam room. The genetic makeup, metabolism, lifestyle, and health history of the actual person receiving care all shape how that care should be delivered. As genetic testing, biomarker panels, and digital health tools become more accessible, healthcare professionals have a growing set of tools to close the gap between population averages and individual outcomes, and an increasing responsibility to use them. The National Institutes of Health has framed this shift plainly: medicine has long relied on an expected “average” response, and precision medicine exists to correct for the patients that approach leaves behind. For healthcare professionals looking to build these principles into their own practice, resources like AIHCP’s continuing education and certification programs offer a practical next step toward more individualized, patient-centered care.

References

  1. Medical Laboratory Observer. (n.d.). The role of pharmacogenomics in precision medicine.
  2. PMC. (2024). The role of pharmacogenomics studies for precision medicine among Ethiopian patients and their clinical implications: A scoping review.
  3. IntechOpen. (2023). Pharmacogenomics – A prospective journey towards precision medicine.
  4. PMC. (2023). Drug-microbiota interactions: An emerging priority for precision medicine.
  5. Psychiatric Times / Carlat Publishing. (2024–2026). STAR*D reanalysis and antidepressant remission rate coverage.
  6. PMC. (2018). Pharmacogenomic impact of CYP2C19 variation on clopidogrel therapy in precision cardiovascular medicine.

 

About the Author

Amanda Collins is a healthcare writer and patient advocacy specialist with over a decade of experience covering clinical practice, care coordination, and health system design. Her work focuses on translating complex health policy and research into rigorous, evidence-informed content for clinical professionals. Amanda has contributed to a range of professional health publications and holds a particular interest in neurodevelopmental intervention, chronic disease management, and the structural determinants of healthcare quality.

 

 

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Why Feeling Better Doesn’t Always Mean You’ve Recovered

Posted on by Joseph Gerard

Is your teen depressed? Please also review AIHCP's Child and Adolescent Grief Counseling Certification

Written by Marko,

After a long time, you’ve slept through the night and, when your friend made a joke, you actually laughed at it. You have plans for the weekend and, for the first time in forever, you’re looking forward to it instead of thinking about how to get out of it. 

It seems like you’re back to being yourself. It was a long way to go, but you did it. You’re okay.

Then… Well, then you realize you won’t make the deadline at work and the same thing happens again. And this is unfortunately something that (likely) resonates with a lot of people.

You feel this knot in your stomach, and you get overwhelmed by panic. It all rushes right back, as if it never left. As if you never made any progress whatsoever. As if you haven’t recovered.

By triggering the HPA axis and increasing your cortisol levels, stress can reactivate previously reduced symptoms. – Harvard Health, Stress Response and Mental Health

That whiplash can be terrible in more ways than one, but it certainly doesn’t mean that you haven’t made serious progress. This is a normal part of the process, so it’s weird that it’s not talked about more. What feels like recovery doesn’t have to mean actual recovery, and what feels like a failure isn’t failure in the vast majority of cases.

Strange, isn’t it?

Let’s see why this happens.

Feeling Better and Being Recovered Aren’t the Same Thing

You no longer feel heavy, and the dark thoughts seem to be gone. 

And while this definitely is a good thing, this is still not what we consider ‘recovered’; it’s only progress towards this goal.

Clinical mental health recovery requires two things: symptom remission and restoration of functioning (work, social, cognitive). – National Institute of Mental Health (NIMH), Mental Illness & Recovery

Maybe you don’t feel that paralyzing panic anymore, but you can’t focus on the book you’re reading for more than 2 minutes. Sure, our mood might be better, which is great, but you still don’t feel motivated enough to shower or run errands you should’ve completed days/weeks ago; you’re procrastinating. 

It’s great that you feel less emotional pain, but that doesn’t necessarily mean that you can function normally again, which is why people tend to get stuck at this stage. It’s also the reason why feeling awesome for a few days can be so deceptive.

Recovery is complicated. Well, that goes without saying, really. 

But what makes it complicated?

People are different, and it comes as no surprise that the recovery process isn’t equal for everyone. There are some things that everyone does share – that’s the fact that there’s no moment where you instantly go from zero to hero. 

There’s no switch.

Mental health recovery is non-linear, meaning it has periods of improvement, periods of relapse, and periods of stabilization. – Substance Abuse and Mental Health Services Administration (SAMHSA)

Recovery is (usually) slow and messy, with a decent amount of back and forth, where you feel like you’re okay one day, and then the next, you feel like everything you did is wrong and all the work was for nothing. 

So, once you get that string of good days, it’s tempting to just declare you’ve recovered and move on with your life.

Relapse rates for mental health conditions (e.g., depression, anxiety) have recurred in 50-80% of people. – National Institute of Mental Health (NIMH), Depression Recurrence Studies

But no mental health professional would agree with you. 

They’ll pat you on the back for having a few good days, but they’ll also want to see if those days become months, especially when something stresses you out. They’ll want to see that you’re still stable even under pressure because, if you are, then you’re truly okay.

This is also why treatment can change at this point. 

Once the worst is over, the focus goes to building something that lasts.

These early improvements can be quite misleading because people start feeling relief, which is both real and welcome, to the point that they assume they’re healed (or at least mostly healed), while in reality, they’re nowhere near full recovery.

One good thing to remember is that you can always ask for help – in fact, it’s encouraged. 

Being among people who know how to help and people who’ve been where you are right now can be the difference between success and failure. This is why hospitalization institutions come in handy. You can find partial hospitalization in Delaware, Ohio, Texas, Maryland, etc. – all over the country. These types of institutions were designed to make your recovery process as efficient and as easy as possible. 

If you’re struggling, then professional help is the answer.

Recovery Happens in More Than One Area

There’s a lot of misinformation out there about recovery, so it’s really no wonder that many people assume it’s this big moment where you wake up one day, and you’re suddenly great. 

But that’s not how recovery works.

Emotional Relief Doesn’t Mean You Can Function Normally

On the one hand, you feel calm. Or at least calmer than you’ve been recently. 

But on the other hand, you find yourself staring at a computer screen for an hour without doing anything. This happens a lot – panic and sadness ease up, but concentration and motivation are nowhere to be found. This is normal. 

Your brain has been running on empty for so long, it makes sense that it needs a while to rebuild cognitive muscles.

You Have to Rebuild Healthy Routines

Behavioral activation is one of the most effective evidence-based methods for sustaining mental/emotional recovery. – American Psychological Association

When things start to go downhill, the first thing people forget about are routines. And it makes sense, because who wants to go to the gym when you feel like your life is falling apart? 

You no longer sleep well, you don’t eat on time, and when you do, it’s not anything healthy because you don’t feel like cooking.

Once your mood picks up, none of this will be magically fixed. 

What you’ll need to do is force yourself to exercise again, to cook, to run errands on time, to go to bed at a certain hour, and so on. 

It won’t feel too good, and you might still end up doomscrolling on TikTok until 3 A.M., but if you keep at it, all of this will become normal again.

Relationships Recover at Their Own Pace

Just because you no longer feel depressed 24/7 doesn’t mean you want to reach out to your friends and family. It’s been so long since you stuck to a plan without flaking or since you were in the company of other people without feeling irritated, so it’s no wonder this feels awkward.

This will take time, probably more than you think.

Get ready to have some awkward conversations with the people around you because they don’t know what to expect of you or even how to act around you. 

Just be honest and let time do its thing. There’s really nothing else to be done here.

Confidence Gets Back Little By Little

Repeated successes increase self-efficacy, which is linked to sustained long-term mental health recovery. – American Psychological Association

If you feel better, that’s a great sign. But the question is, “How are you doing mentally REALLY?” Do you believe in yourself again? Do you feel good about yourself?

Once you’ve managed to tackle these heavy emotions, that doesn’t automatically mean that confidence is back. 

The way you get back your confidence is by being consistent and steady. 

Keep giving yourself small and achievaeable/realistic goals. 

The more you complete them, the better you’ll feel because this will train your mind that progress is REAL. It’s not some abstract concept. Once you realize that your actions can make a difference, your confidence will (slowly) return.

What Actual Recovery Looks Like

As you may have figured out by now, recovery doesn’t look perfect. It actually looks kind of basic, with a little bit of chaos here and there. 

True/proper recovery you’ll find in the form of consistency.

One bad day is just that – a bad day. It doesn’t unravel into something that lasts for weeks, so one bad day is actually progress.

If you want to know about the biggest sign of recovery, it’s simple. 

It’s in how someone handles stress once it shows up. The important thing here is that they’ll deal with it instead of running away. They’ll sit with the discomfort they feel because they’re strong and don’t have to hide from the bad stuff anymore.

Another thing that happens once a person starts to recover is that they notice more meaningful stuff in their life. 

Like their job, for example. 

It no longer feels soul-sucking but worthwhile. 

All these relationships start becoming a source of comfort and connection instead of something that constantly drains you and makes you feel uncomfortable. Stress and the struggle won’t disappear. Everyone gets stressed out, and everyone struggles at one point or another. It’s how we face those things that change (for the better).

Conclusion

Someone who now sleeps better and laughs at jokes is winning life.

Don’t take feeling good for granted. This doesn’t mean that you don’t deserve feeling good – you do. But keep in mind that it takes a lot of work (whether you realize it or not) to keep feeling good and staying positive even though the odds might be against us.

We can do it, of course. 

But once we start feeling a bit too comfortable; once we start getting lazy, all those bad things in life will again start knocking harder at our doors.

The main takeaway here is that you now KNOW that it’s possible; and it’s not THAT difficult once you know what to do and how to do it. You just have to be aware at all times, and you have to train yourself.

​

2 Interlinking Opportunities:

From https://aihcp.net/2025/10/22/emotional-healing-process-in-counseling/ with anchor approach to emotional recovery

From https://aihcp.net/2024/11/21/psychological-recovery-after-crisis/ with anchor limitations of recovery

Author Bio 

Marko is an adamant and eager content writer with a decade of experience in various niches,  with healthcare being one of them. With his way of implementing storytelling, comparisons, and examples into hard-to-grasp topics, Marko’s able to make complex things sound interesting and relatable – key ingredients to make something understandable. As a hobby, Marko enjoys offroading, board games, and spending time with his family and his dog Cezar.

 

 

Please also review AIHCP’s Grief Counselor Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification